| Factor Information | |
|---|---|
| Data ID | 1492 |
| Factor | PH -admission of TGA |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | infant with HLHS |
| p Value | <0.001 |
| Conclusion | Lack of PGE availability remained significantly associated with higher PH in the TGA group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 69 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS |
| Reference | |
|---|---|
| PMID | 26499357 |
| Year | 2016 |
| Title | Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | infant | |
| Source | data | |
| Region | Houston, USA | |
| Method | multivariable analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PGE stock of TGA(Treatment) | No PGE stock of TGA(Control) |
| Number | 88 | 8 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 7.32±0.09mg/dl | 7.44±0.08mg/dl |
